Sandoz Adds To Anti-Infectives With Astellas Mycamine Deal

Global Micafungin Rights Valued At Up To $75m Upfront Plus Milestone Payments

 
• By David Wallace
  
Sandoz logo on building
Sandoz and Astellas have struck a deal for Mycamine • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business